Clinical Outcomes, Nutritional Status, Exercise and Psychosocial Factors in Pediatric Hematopoietic Cell Transplant



Status:Recruiting
Conditions:Food Studies, Obesity Weight Loss
Therapuetic Areas:Endocrinology, Pharmacology / Toxicology
Healthy:No
Age Range:2 - 25
Updated:11/1/2018
Start Date:November 2015
End Date:February 2020
Contact:Sung Won Choi, MD, MS
Email:sungchoi@med.umich.edu
Phone:734-615-5707

Use our guide to learn which trials are right for you!

Children who receive hematopoietic cell transplants (HCT) are at high nutritional risk due to
comorbidities and complications that are likely to develop before, during and after
transplant. Prior to transplant, many children undergo multiple rounds of chemotherapy which
affect appetite and cause gastrointestinal toxicities that limit food intake. During
transplant, painful mucositis makes it difficult to consume adequate nutrients and often
children will require nutrition support such as parenteral or enteral nutrition. Energy
imbalance and physical deconditioning following transplant can result in loss of lean body
mass and functional impairment; these nutritional side effects are exacerbated if the child
develops graft-versus-host disease. After transplant, a substantial number of childhood
cancer survivors become overweight and develop metabolic syndrome. However, little is known
about the prevalence and distribution of pediatric malnutrition (under-nutrition as well as
obesity), the psychosocial factors that affect dietary intake and how the quality of the
child's food intake and physical activity level throughout the transplant process might
affect body composition and clinical outcomes. In this exploratory study, we will monitor
nutritional status in pediatric patients undergoing HCT. This study will test the feasibility
of collecting patient-reported dietary intake data along with anthropometric, body
composition, functional status and psychosocial measurements that may influence dietary
intake in pediatric patients undergoing HCT. The data collected in this preliminary analysis
will inform future interventional studies.


Inclusion Criteria:

- Pediatric hematopoietic cell transplant patients, aged 2-25 years.

- Participants and/or at least one caregiver must speak, read and understand English.

Exclusion Criteria:

- Children younger than 2 years old at the time of their transplant or any child who is
still breastfeeding will not be eligible due to the nature of the questionnaires and
measurements.
We found this trial at
1
site
1500 E Medical Center Dr
Ann Arbor, Michigan 48109
(734) 936-4000
Principal Investigator: Sung Choi, MD, MS
Phone: 734-615-5707
University of Michigan Health System The University of Michigan is home to one of the...
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials